![]() | ![]() |
Formats:
|
||||||||||||||||||||
Phosphatidylcholine synthesis is required for optimal function of Legionella pneumophila virulence determinants 1Department of Molecular Biology and Microbiology, Tufts University School of Medicine, 150 Harrison Avenue, Boston, MA 02111, USA 2 Centro de Ciencias Genomicas, Universidad Nacional Autonoma de Mexico, Apartado Postal 565-A, Cuernavaca, CP62210, Morelos, Mexico 3Howard Hughes Medical Institute. 3Corresponding Author E-mail: ralph.isberg/at/tufts.edu 4Current address: Dept. of Cell Biology and Anatomy, University of Arizona College of Medicine, Tucson, AZ 85724 5Current address: Department of Biological Sciences, Purdue University, West Lafayette, IN 47907 5Current address: Centro de Investigaciones en Biotecnología, Universidad Autónoma del Estado de Morelos, Cuernavaca, Mexico. The publisher's final edited version of this article is available at Cell Microbiol. See other articles in PMC that cite the published article.Abstract The function of phosphatidylcholine (PC) in the bacterial cell envelope remains cryptic. We show here that productive interaction of the respiratory pathogen Legionella pneumophila with host cells requires bacterial PC. Synthesis of the lipid in L. pneumophila was shown to occur via either phospholipid N-methyltransferase (PmtA) or phosphatidylcholine synthase (PcsA), but the latter pathway was demonstrated to be of predominant importance. Loss of PC from the cell envelope caused lowered yields of L. pneumophila within macrophages as well as loss of high multiplicity cytotoxicity, while mutants defective in PC synthesis could be complemented either by reintroduction of PcsA or by overproduction of PmtA. The lowered yields and reduced cytotoxicity in mutants with defective PC biosynthesis were due to three related defects. First, there was a poorly functioning Dot/Icm apparatus, which delivers substrates required for intracellular growth into the cytosol of infected cells. Secondly, there was reduced bacterial binding to macrophages, possibly due to loss of PC or a PC derivative on the bacterium that is recognized by the host cell. Finally, strains lacking PC had low steady state levels of flagellin protein, a deficit that had been previously associated with the phenotypes of lowered cytotoxicity and poor cellular adhesion. INTRODUCTION Legionella pneumophila is a Gram-negative respiratory pathogen that causes severe pneumonia in immunocompromised individuals as well as occasional community-wide epidemic outbreaks resulting from single-source aerosols (Chow and Yu, 1998; Fraser et al., 1977). After deposition in human lungs, the organism grows within alveolar macrophages, which fail to degrade the bacterium, and instead allow the formation of a membrane-bound replication vacuole (Nash et al., 1984; Horwitz, 1983). A remarkable aspect of the natural history of the disease is that growth in host macrophages appears to mimic the strategy used by the microorganism to replicate within amoebae in the environment (Rowbotham, 1980). The bacterium probably has intimate interaction with unicellular eukaryotes during extracellular growth in the environment, as L. pneumophila primarily inhabits complex biofilms, such as those that develop in plumbing sources prior to aerosol contact with humans (Rogers et al., 1994). Therefore, in addition to being an intracellular parasite, the bacterium comes into contact with unique metabolites provided by eukaryotic hosts in its environmental reservoir. Intracellular growth and formation of the replication vacuole requires the Dot/Icm secretion system, a multiprotein complex in the bacterial envelope that allows translocation of macromolecules across host cell membranes (Sexton and Vogel, 2002; Segal and Shuman, 1999; Vogel et al., 1998). L. pneumophila strains that properly assemble this complex recruit membranous material derived from host cell early secretory compartments, and this contributes to the formation of the replication vacuole containing the bacterium (Derre and Isberg, 2004; Kagan et al., 2004; Kagan and Roy, 2002; Swanson and Isberg, 1995). A number of bacterial proteins have been identified that are translocated by the Dot/Icm system across the vacuolar membrane, presumably manipulating host cell signaling and survival pathways (Chen et al., 2004; Conover et al., 2003; Luo and Isberg, 2004; Nagai et al., 2002; Shohdy et al., 2005) (Gao and Abu Kwaik, 1999). The absence of certain components of the Dot/Icm apparatus (DotL, DotM and DotN) results in lowered plating efficiency of bacteria on solid medium, probably because a partially assembled Dot/Icm lacking these components is misregulated (Buscher et al., 2005; Conover et al., 2003). To identify proteins that may regulate the function or assembly of the Dot/Icm system, a genetic screen was performed to isolate insertion mutations that had phenotypes similar to dotL mutations. As seen with dotL mutations, strains isolated from this mutant hunt all showed lowered viability in the presence of overproduced DotA, a component of the apparatus, but showed normal viability in strains making either no or low levels of DotA (Conover et al., 2003). One of the mutants that had reduced plating efficiency in the presence of DotA overproduction had an insertion in the lidK gene (lpg1584), predicted to encode phosphatidylcholine synthase (Pcs), a recently discovered enzyme that allows the synthesis of phosphatidylcholine (PC) lipids in some bacterial species (Sohlenkamp et al., 2000; de Rudder et al., 1999). In a separate study, lidK (or pcsA to denote its activity) was shown to be one of a number of orfs from a variety of bacterial species that can promote the production of PC when overexpressed in E. coli, consistent with lidK/pcsA encoding a Pcs (Martinez-Morales et al., 2003). PC is a major essential component of eukaryote membranes, but only a fraction of bacterial species synthesize this phospholipids (Wilderman, et al, 2002). Many of the bacterial species that produce PC are found intimately associated with eukaryotic hosts (Sohlenkamp et al., 2003). Those bacteria that synthesize PC do so via one or more enzymatic pathways, and the enzymatic activities for two of these pathways have been identified in L. pneumophila by genomic searches (Fig. 1A
There is little information regarding why some bacteria species have PC in their envelopes. The most striking phenotype for PC-deficient mutants is in the plant pathogenic Agrobacterium tumefaciens, in which the lack of PC has the unexplained effect of reducing transcription of genes encoding components of the T DNA conjugative apparatus (Wessel et al., 2006). Mutations causing a PC deficit in other microorganisms that interact with host cells similarly cause alterations in host cell relationships. For instance, Bradyrhizobium japonicum PC mutants show inefficient symbiosis with the soybean host plant (Minder et al., 2001), while Brucella mutants unable to synthesize PC have lowered virulence in a mouse model and less efficient replication vacuole formation (Comerci et al., 2006; Conde-Alvarez et al., 2006)). In this work, we demonstrate that the presence of PC in L. pneumophila is important for both adhesion to host cells as well as for function of the Dot/Icm system. The loss of PC results in the absence of the flagellin protein, a posttranscriptional defect that may be the major cause of altered host cell interactions observed in PC-defective mutants. RESULTS Mutations in lidK/pcsA gene reduce the plating efficiency of L. pneumophila in the presence of high-level expression of the dotA gene (Conover et al., 2003). Therefore, for most experiments presented here, bacterial strains were used that produced low levels of the DotA protein encoded by derivatives of the plasmid pGC36. Such strains grow within macrophages, although there is some reduction in the efficiency of effector translocation relative to wild type strains. Strains expressing low levels of DotA show normal viability on bacteriological media in the presence of a lidK/pcsA mutation (Conover et al., 2003). Mutations in the L. pneumophila lidK/pcsA gene result in reduced phosphatidylcholine content It has been reported that phosphatidylcholine (PC) represents approximately 30% of the L. pneumophila phospholipid (Hindahl and Iglewski, 1984). To determine if the demonstrated phosphatidylcholine synthase activity of the lidK/pcsA gene product (Martinez-Morales et al., 2003) contributes to the steady state level of this phospholipid, bacteria were grown in broth to post-exponential phase (A600=3.5), labeled with [1-14C]acetate, and total lipids were extracted and separated by 2-dimensional thin layer chromatography (Fig. 1B-E Although PC represented only a small fraction of the phospholipid found in the pcsA− mutant, this amount increased with storage at −80°C and subsequent recovery of CFU at 37°C. Therefore, a deletion of pcsA was constructed and analyzed soon after isolation. The amounts of PC in this strain were extremely low, indicating that continued storage selects for isolates with enhanced PC content (Fig. 1E; CCL24 As the pcsA− mutants showed varying amounts of residual PC in membrane extracts, we isolated a strain lacking both pmtA and pcsA. Although isolation of the double mutant required a two-step procedure, in which the ΔpmtA allele was crossed into a ΔpcsA/ppcsA+ heterozygote followed by curing of the wild type pcsA+ gene, strains lacking both enzymes in PC biosynthesis grew as well in bacteriological medium as did the parental ΔpcsA single mutant (data not shown). The resulting double mutant (pcsA::GmR ΔpmtA) grown to postexponential phase showed no detectable levels of PC after chromatographic analysis of phospholipids (CCL26; Fig. 1E L. pneumophila lacking PC results in reduced yields after infection of macrophages Strains lacking either one or both pathways of PC biosynthesis were analyzed for their ability to grow within mouse bone marrow-derived macrophages (Fig. 2A and B
The observed depression in intracellular growth caused by a deficit in PC synthesis may result from a poorly functioning Dot/Icm translocator, which would interfere with the ability of the microorganisms to direct formation of the morphologically distinct replication vacuole. Alternatively, the bacteria could proliferate slowly once a properly constructed vacuole is formed. These possibilities can be distinguished, because mutations that impair translocator function result in strains that traffic to the macrophage endocytic network. Furthermore, interference with Dot/Icm function should result in depressed efficiency of substrate translocation into target cells. To test for defective trafficking of the L. pneumophila-containing vacuole, macrophages incubated for one hour with bacteria were assayed for colocalization of this compartment with the endocytic marker LAMP-1 (Andrews et al., 1998). About 2-3 times as many pcsA− bacteria colocalized with LAMP-1 compared to the low DotA expressing control (Fig. 3A
The lack of PC also led to a reduction in the efficiency of effector translocation (Fig. 3B Defective adhesion to macrophages by PC mutants From the growth curves (Fig. 2A
The absence of the pmtA gene caused an unexpected effect. Although the ΔpcsAΔpmtA double mutant was defective for uptake by macrophages, the simple loss of pmtA from L. pneumophila resulted in a modest stimulation of bacterial association with macrophages (Fig. 4C The possibility that lipid derivatives could interfere with PC-dependent uptake was further pursued. Absence of bacterial PC could indirectly reduce uptake by interfering with the ability of the bacterium to export a ligand that is bound by a cellular receptor, or directly, by preventing the synthesis of a PC-derived molecule that is recognized by the macrophage. There is precedent for respiratory pathogens using choline-derivatives as ligands for recognition by cellular receptors, in which case adhesion is inhibited by small molecule PAF receptor antagonists (PAF-Ra) (Swords et al., 2000; Cundell et al., 1995). When a PAF-Ra was added during a short incubation of bacteria with macrophages, it specifically interfered with uptake of the pcsA+ strains, and had no effect on association of the ΔpcsAΔpmtA mutant (Fig. 4D The absence of PC interferes with selected functions associated with bacterial transmission to macrophages A number of L. pneumophila virulence-associated functions are preferentially induced during the post-exponential phase of growth, and the induction of these factors is correlated with efficient establishment of intracellular growth (Hammer et al., 2002; Byrne and Swanson, 1998). These properties include the Dot/Icm-dependent induction of macrophage cell death after high multiplicity infection, enhanced bacterial motility, and the induction of expression of translocated substrates of the Dot/Icm system (Luo and Isberg, 2004). Each of these properties was analyzed. Rapid cell death to macrophages resulting from bacterial contact-dependent high multiplicity infection has been attributed to the insertion of a bacterium-derived pore into host macrophages by the Dot/Icm system (Zink et al., 2002; Kirby et al., 1998). To assay for this function, macrophages were allowed to come into contact with bacteria for one hour (Fig. 5A-D
The defective cytotoxicity is attributed to either defective Dot/Icm assembly (Kirby et al., 1998) or an inability of the bacterium to assume a state of heightened competence for intracellular growth that has been closely correlated with entry into postexponential phase of broth culture (Molofsky and Swanson, 2004). This latter property has been penned the “Transmission Phenotype” to denote that the postexponential phase allows the bacteria to be transmitted from an extracellular locale to an intracellular niche and initiate replication efficiently (Molofsky and Swanson, 2004). To test for properties that are similarly associated with the Transmission Phenotype, the PC-defective mutants were assayed for motility and growth phase-dependent expression of translocated substrates. Mutants lacking PcsA were highly defective for establishing a motile state in postexponential phase (Fig. 6A
Although two phenotypes (motility and cytotoxicity) associated with the Transmission Phenotype were defective in mutants lacking PC, the mutants were still able to respond to postexponential phase signals based on the levels of translocated Dot/Icm substrates associated with the bacteria. In postexponential phase cultures, bacteria accumulate the translocated substrate VipD (Fig. 6B, “P;” As the lack of motility was unlikely to be due to general misregulation of post-exponential phase transcription, we looked directly for a loss in the steady state levels of flagellin protein due the absence of PC (Fig. 6B In contrast to the lowered flagellin levels observed in the absence of PC, the expression and stability of individual components of the Dot/Icm complex appeared unaffected. Immunoprobing with antibody directed against inner membrane components DotF, DotG and DotO, the outer membrane protein DotH and the cytoplasmic IcmQ showed that steady state levels for each of these proteins were identical in wild type, ΔpcsAΔpmtA, and ΔpcsAΔpmtA/ppcsA+ strains (Fig. 7
DISCUSSION As most bacterial species do not have the capacity to synthesize phosphatidylcholine (PC), the reason for the presence of PC in some bacterial species has remained mysterious. It was originally proposed that bacteria with large amounts of internal membranes, such as photosynthetic bacteria, have a requirement for this lipid (Hagen et al., 1966). Interestingly, several species that interact intimately with host cells have significant PC content in their membranes, so this lipid may play an important function in allowing these microorganisms to interface with their hosts (Lopez-Lara and Geiger, 2001; Goldfine, 1984). There had been little information supporting this hypothesis, and each species having PC may synthesize the lipid for a different reason. The original observation supporting its importance was the demonstration that mutations depressing PC synthesis in the nitrogen fixing Bradyrhizobium japonicum cause reduced root nodule occupancy (Minder et al., 2001). Similarly, Brucella abortus mutants defective for synthesis of PC show unexplained defects in cell interactions and virulence (Comerci et al., 2006; Conde-Alvarez et al., 2006). The clearest connection between a molecular defect and a phenotype is the case of A. tumefaciens, in which loss of virulence in PC-defective mutants results from lowered transcription of the genes encoding the T DNA transfer apparatus, a result very different from what we observed with the Dot/Icm complex (Fig. 7 The low yield of bacteria after infection of macrophages by PC- mutants appears to be the consequence of two related defects: poor initiation of intracellular replication and a defect in the ability of the bacteria to associate with macrophages. Once initiation of replication occurs, however, the rate of replication of these mutants did not appear strongly altered by the absence of PC. This small effect on replication rate is somewhat surprising given the increased association with LAMP-containing compartments for mutants relative to wild type. Having a lowered initial level of infection, however, could be the result of both an uptake defect as well as loss of viability of the improperly targeted bacteria. Therefore, the viable PC- mutants seen at early timepoints may be primarily those that have targeted properly and which will eventually replicate. Furthermore, different initial doses of infected macrophages results in nonidentical monolayer conditions that can greatly affect the rate of bacterial intracellular replication. For instance, we have observed that at low MOI, there is a detectable cytokine response that is a function of bacterial infectivity levels (M. Liu and R. Isberg, data not shown). This response, in which monolayers having lower numbers of viable bacteria result in less restriction of L. pneumophila growth, makes it difficult to directly correlate replication rates to targeting defects. There is a large body of work indicating that L. pneumophila entry into post-exponential phase allows expression of functions required for productive growth in macrophages (Byrne and Swanson, 1998). We found that the loss of PC interfered with proper function of a subset of activities associated with this state, such as cytotoxicity, motility, cell association and intracellular growth (Molofsky and Swanson, 2004). These defects did not appear to be a result of an inability to respond to signals resulting from nutrient depletion, as cultures of wild type strains and PC- mutants showed identical induction of both translocated substrates and the flagellin structural gene after entry into post-exponential phase. The absence of PC, however, did result in the loss of flagellin protein even though the flaA structural gene transcript was strongly induced in post-exponential phase (Fig. 6 The second explanation for the role of PC is that the choline head group directly interacts with target cells. In particular, some mucosal pathogens are believed to use bacterial surface molecules that have been modified by phosphorylcholine as ligands for host cell receptors (Swords et al., 2000; Cundell et al., 1995). The PC head group could act as a source for such modifications. The primary evidence that bacterial phosphorylcholine is recognized by mammalian receptors are studies indicating that an antagonist of platelet activating factor receptor (PAF-Ra) interferes specifically with adhesion of phosphorylcholine-modified bacterial ligand (Swords et al., 2000; Cundell et al., 1995). As PAF has a phosphorylcholine group, it is attractive to speculate that mammalian receptors that recognize the PAF-Ra antagonist also recognize phosphorylcholine-modified bacterial cell surfaces. Similar to results in Streptococcus pneumoniae and Haemophilus influenzae, we found that the PC-dependent cell adhesion of L. pneumophila could be blocked by the addition of a PAF-Ra, with adhesion of a mutant lacking PC being totally resistant to the action of the antagonist (Fig. 4 The clear preference of L. pneumophila for using PcsA, rather than the PmtA pathway must be explained. One possibility is that the products of the PmtA pathway negatively impact either bacterial viability or the ability of the organism to interact with the host. Unlike PcsA, which only produces PC as a product, the PmtA pathway results in low-level synthesis of the monomethylated and dimethylated derivatives of phosphatidylethanolamine, which have uncertain roles in membrane biology. These lipids could interfere with either adhesion of the cells or assembly of membrane proteins. A second explanation for the predominance of the PcsA pathway is that the synthase is a direct sensor of environmental conditions, using choline availability as an indicator of the status of the locale in which the bacterium is found. Limiting choline concentrations may be a signal for the bacterium to either slow its growth or make compensatory changes in lipid side chain composition to accommodate environments in which choline is limiting. The presence of large pools of choline could be a signal for the bacterium that host cells are available for intracellular replication, allowing the proper assembly of envelope components critical for host cell interaction. Although it may be counterintuitive that the bacterium relies on an extracellular source of precursor rather than utilize its own biosynthetic pools, the fact that interaction with hosts is a central aspect of the biology of L. pneumophila must be an important determinant of how this preference for PcsA arose. PC synthesis appears to be a critical sensor of the nature of the environment surrounding the microorganism. Biosynthetic precursors found in lung tissue, therefore, can modulate virulence of this organism by controlling the ability of the organism to incorporate PC into its cell envelope. Investigating how the environment controls the PC content in cells and how this phospholipid modulates host cell interaction are of central importance for understanding the pathogenesis of L. pneumophila. EXPERIMENTAL PROCEDURES Bacterial strains, plasmids, cell culture and media The bacterial strains and plasmids used in this study are listed with their relevant characteristics in Table 1. The L. pneumophila strains used are derivatives of the L. pneumophila Philadelphia 1 strain Lp02 (thyA Δ[hsdR-lvh] rpsL) (Berger and Isberg, 1993), and were grown on casamino acids-yeast extract (CYE) solid medium or ACES-yeast extract (AYE) broth (Berger and Isberg, 1993). For L. pneumophila, antibiotics were used at the following concentrations: chloramphenicol, 5 μg/ml; kanamycin, 40 μg/ml; streptomycin, 50 μg/ml; and gentamicin, 50μg/ml. The growth media were supplemented with thymidine at 100 μg/ml or 5% sucrose when appropriate. The L. pneumophila strains used in all assays were grown to post-exponential phase (OD600 ≈ 3.2 – 3.5) unless stated otherwise. Antibiotics were used at the following concentrations with E.coli strains: kanamycin, 40 μg/ml; ampicillin 100 μg/ ml and chloramphenicol, 30 μg /ml.
All DNA manipulations were as described previously (Conover et al., 2003). Primary bone marrow-derived macrophages were isolated from the femurs of female A/J mice and maintained as described (Swanson and Isberg, 1995). Typically, 1×105 macrophages were plated per well for immunofluorescence studies, and 4-5 × 105 macrophages per well were used to monitor bacterial growth. Construction of the pcsA and pmtA deletion mutants The pcsA(lidk)::miniTn10 insertion was isolated previously (Conover et al., 2003). The ΔpmtA deletion on the L. pneumophila chromosome was isolated by first constructing an internal deletion in pmtA using PCR generated fragments, leaving 6 amino acids at the amino terminus and 3 amino acids at the carboxyl terminus (Supplemental Data). These were then cloned on the suicide plasmid pSR47s (kanRsacB) to generate the plasmid pGD51. The plasmid was introduced into appropriate L. pneumophila strains as described (Conover et al., 2003). After selecting for integration by plating on kanamycin-containing medium, transconjugants were purified and plated onto 5% sucrose CYET plates to select for sucrose resistant recombinants that had lost the plasmid. Construction of the ΔpcsA::GmR mutant used the same strategy, with a GmR fragment inserted into a total deletion of the pcsA (lidK) gene in the suicide plasmid pSR47s (Supplemental Data). Construction of the ΔpcsA::GmR ΔpmtA double mutation in a strain harboring the plasmid pGC41td+pcsA+ (Thy+) is described in the text (Fig. 2 Construction of complementation plasmids The two complementing plasmids encoding the complete ORFs of pcsA (pGC41) and pmtA (pTC5) were constructed in the plasmid pGC36 (Conover et al., 2003) by placing each gene under the control of Ptac in an operon with td?i. The complementing genes containing sufficient upstream DNA to allow efficient translation were amplified by PCR from chromosomal DNA using primers with the indicated engineered restriction sites. Lipid profiles of L. pneumophila PC mutants L. pneumophila cultures (1 ml) were grown in AYE at 37°C to an optical density of A600=3.5, labeled for 40 min with 5 μl of [1-14C]acetate (60 mCi/mmol; 200 μCi/ml) and subsequently harvested. Lipids were then extracted (Bligh and Dyer, 1959) and analyzed by 2-D thin layer chromatography (TLC) (de Rudder et al., 1997). The TLC plates were exposed to Kodak X-Omat film, lipid spots were scraped, and quantified by liquid scintillation counter. In addition to the results reported, strains growing in exponential phase were also analyzed, using an identical approach. LAMP-1 targeting assay L. pneumophila strains were grown and tested in the LAMP-1 targeting assay exactly as previously described (Conover et al., 2003). The number of LAMP-1-positive phagosomes per bacterial strain was quantified by counting cell-associated bacteria per strain (N = 312). The average and standard deviation reported here were calculated from three independent infections per strain. Intracellular growth assays Intracellular growth curves were performed in bone marrow-derived macrophages from the A/J mouse as described, incubating macrophages with bacteria at an MOI ≈ 0.05 or as indicated (Conover et al., 2003). Each experiment was performed in triplicate. To examine microscopically the intracellular growth of L. pneumophila inside macrophages, mammalian cells were plated at density of 1×105 per coverslip and infected with the indicated strains at MOI ≈ 1, fixed in in PLP-sucrose (McLean and Nakane, 1974) and analyzed as described previously (Conover et al., 2003). The number of intracellular bacteria in each phagosome in separate macrophages was recorded by visual inspection. Data shown represent the distribution of phagosomes containing 1 to 3, 4 to 9 and more than 10 bacteria. These data were calculated by averaging triplicate samples of 104 scored phagosomes per coverslip. Cytotoxicity assay Contact dependent cytotoxicity assays were performed in macrophages plated on coverslips 24 hours prior to infection, as described performing 1 hour infections at 37°C in 5% CO2 (Kirby et al., 1998). Pore-forming activity was measured as the percentage of total cells that stained positive for ethidium bromide relative to acridine orange stained cells. Immunofluoresence assay of bacterial uptake and SidC translocation Mammalian cells were plated one day prior to infection with the indicated post-exponentially grown motile L. pneumophila. Unless otherwise indicated, the infected macrophages were spun for 5 minutes and the infection proceeded at 37°C for the times indicated, until stopped by three washes with RPMI medium. Samples were fixed in PLP- sucrose and stained for extracellular bacteria with rabbit anti-L. pneumophila serum and Texas Red-anti rabbit IgG. The monolayers were then methanol permeabilized (Conover et al., 2003) and stained with rabbit anti-L. pneumophila serum and FITC-anti rabbit IgG to detect total bacteria. Percentage of internalized/bound bacteria was scored as fraction of bacteria resisting staining with Texas Red-IgG but which stain with FITC-IgG. The data reported in each experiment is the average of triplicate infections scoring 104 macrophages per coverslip. Translocation of the Dot/Icm substrate SidC was performed as described (Luo and Isberg, 2004; Conover et al., 2003). Macrophages were incubated with noted bacterial strains for one hour, and fixed samples were then probed with affinity purified rabbit anti-SidC and rat anti-L. pneumophila, followed by detection with fluorescent secondary antibodies. 104 phagosomes per coverslip were scored, and data were expressed as mean percentage of phagosomes showing staining for SidC ± S.D. Assay for bacterial uptake in platelet activating factor receptor antagonist (PAF-Ra) treated macrophages Platelet Activating Factor-16 Antagonist (PAF-Ra, Calbiochem, La Jolla, CA, catalog # 511082) was dissolved in EtOH following manufacturer specifications. The compound was serially diluted in RPMI to obtain the appropriate concentration. Macrophages were pretreated at 37°C with 100 nM PAF-Ra for 30 minutes prior to infection as described (Swords et al., 2000). Once the drug was added to the mammalian cells, they were immediately infected with post-exponential motile L. pneumophila at MOI ≈ 10 for 10 minutes. The infection was stopped by extensive washes and the samples were processed for immunofluorescence as described above. Immunoprobing of L. pneumophila lysates for post-exponential phase expressed proteins For analysis of growth-stage specific expression of proteins, L. pneumophila strains were grown at 37° C in AYE broth. The equivalent of 0.5 OD units of each strain were harvested at both exponential (A600 = 1.0-1.5) and post-exponential (A600 = 3.5-4.0) phases of growth, centrifuged at 16,000 × g to separate bacterial cells from culture supernatants and the resulting supernatants were frozen at −80° C for later analysis. Bacterial cell pellets were then resuspended in 150 μl SDS-PAGE sample buffer and boiled for 5 minutes. 5 μl of each sample was resolved by SDS-PAGE and analyzed by Western blotting using various antisera. For the analysis of flagellin in culture supernatants, frozen supernatants were thawed on ice and trichloroacetic acid was added to a final concentration of 10%. Samples were vortexed for 1 min and incubated on ice for 20 min. Samples were pelleted at 16,000 × g for 10 min and resulting precipitates were washed twice with ice-cold ethanol and air dried for 15 min at 37° C. Dried pellets were then resuspended with 30 μl SDS-PAGE sample buffer and boiled for 5 min. 10 μl of each sample was resolved by SDS-PAGE and analyzed by Western blotting using rabbit antisera against the noted L. pneumophila proteins. Serum specific for B. subtilus isocitrate dehydrogenase (ICDH) was provided by A. L. Sonenshein (Tufts University School of Medicine, Boston MA). Serum specific for flagellin was provided by W. F. Dietrich (Harvard Medical School, Boston MA), antisera directed against L. pneumophila proteins were raised previously in our laboratory. Affinity purified serum directed against VipD has been previously described (VanRheenen et al., 2006). RNA extraction, reverse transcription, and real-time PCR To determine the amounts of flaA transcript in L. pneumophila strains by using realt time quantitative PCR (qPCR), L. pneumophila was grown in AYE medium at 37°C and samples were removed in either late exponential phase (A600= 1.0) or postexponential phase (A600= 3.5) to prepare RNA. Total RNA was then isolated using RNeasy (QIAGEN). Reverse transcription was performed on the samples using 1 μg of RNA with Superscript II reverse transcriptase (Invitrogen) and random decamers (Ambion). qPCR was performed in real time in a Clontech quantitative thermocycling spectrophotometer using the SYBR green PCR master mix (Applied Biosystems) with primers specific for flaA (flaA forward: 5′ CCATCAGCAGCAGTGAGTGT 3′, flaA reverse: 5′TCAATGGCGTCAGTAACCAA 3′) and 16S rRNA (16S forward: 5′ CTAAGGAGACTGCCGGTGGTGAC, 16S reverse: 5′CGTAAGGGCCATGATGACTT 3′). The transcript levels of flaA were normalized to 16s rRNA values for each condition and displayed in graphical format. Supp Data Click here to view.(162K, pdf) Acknowledgments We thank Matthias Machner, Tamara O'Connor, Marion Dorer and Zhiru Li for review of the manuscript. This work was supported by Training Grant T32AI1007422, NIDDK Center Grant P30 DK34928, a fellowship from the Life Sciences Foundation to Z-Q. Luo, an NIH postdoctoral fellowship to M.H. and grants from the Consejo Nacional de Ciencia y Tecnología de México (CONACyT 42578/A-1), as well as the Howard Hughes Medical Institute (HHMI 55003675) to O. Geiger. R. I. is an investigator of the Howard Hughes Medical Institute. REFERENCES
|
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||||||
Semin Respir Infect. 1998 Jun; 13(2):132-9.
[Semin Respir Infect. 1998]N Engl J Med. 1977 Dec 1; 297(22):1189-97.
[N Engl J Med. 1977]J Clin Invest. 1984 Sep; 74(3):771-82.
[J Clin Invest. 1984]J Exp Med. 1983 Dec 1; 158(6):2108-26.
[J Exp Med. 1983]J Clin Pathol. 1980 Dec; 33(12):1179-83.
[J Clin Pathol. 1980]Traffic. 2002 Mar; 3(3):178-85.
[Traffic. 2002]Infect Immun. 1999 May; 67(5):2117-24.
[Infect Immun. 1999]Science. 1998 Feb 6; 279(5352):873-6.
[Science. 1998]Infect Immun. 2004 May; 72(5):3048-53.
[Infect Immun. 2004]J Exp Med. 2004 May 3; 199(9):1201-11.
[J Exp Med. 2004]J Bacteriol. 2005 May; 187(9):2927-38.
[J Bacteriol. 2005]Mol Microbiol. 2003 Apr; 48(2):305-21.
[Mol Microbiol. 2003]J Biol Chem. 2000 Jun 23; 275(25):18919-25.
[J Biol Chem. 2000]J Biol Chem. 1999 Jul 9; 274(28):20011-6.
[J Biol Chem. 1999]Microbiology. 2003 Dec; 149(Pt 12):3461-71.
[Microbiology. 2003]J Bacteriol. 2002 Sep; 184(17):4792-9.
[J Bacteriol. 2002]Prog Lipid Res. 2003 Mar; 42(2):115-62.
[Prog Lipid Res. 2003]Microbiology. 2003 Dec; 149(Pt 12):3461-71.
[Microbiology. 2003]J Biol Chem. 1993 Jul 25; 268(21):16002-8.
[J Biol Chem. 1993]J Biol Chem. 1999 Jul 9; 274(28):20011-6.
[J Biol Chem. 1999]Mol Microbiol. 2006 Nov; 62(3):906-15.
[Mol Microbiol. 2006]Mol Microbiol. 2001 Mar; 39(5):1186-98.
[Mol Microbiol. 2001]J Bacteriol. 2006 Mar; 188(5):1929-34.
[J Bacteriol. 2006]Cell Microbiol. 2006 Aug; 8(8):1322-35.
[Cell Microbiol. 2006]Mol Microbiol. 2003 Apr; 48(2):305-21.
[Mol Microbiol. 2003]J Bacteriol. 1984 Jul; 159(1):107-13.
[J Bacteriol. 1984]Microbiology. 2003 Dec; 149(Pt 12):3461-71.
[Microbiology. 2003]Infect Immun. 1998 Mar; 66(3):950-8.
[Infect Immun. 1998]Proc Natl Acad Sci U S A. 2004 Jan 20; 101(3):841-6.
[Proc Natl Acad Sci U S A. 2004]Proc Soc Exp Biol Med. 1973 Mar; 142(3):1048-50.
[Proc Soc Exp Biol Med. 1973]Mol Microbiol. 2000 Jul; 37(1):13-27.
[Mol Microbiol. 2000]Nature. 1995 Oct 5; 377(6548):435-8.
[Nature. 1995]Mol Microbiol. 2002 Apr; 44(1):107-18.
[Mol Microbiol. 2002]Infect Immun. 1998 Jul; 66(7):3029-34.
[Infect Immun. 1998]Proc Natl Acad Sci U S A. 2004 Jan 20; 101(3):841-6.
[Proc Natl Acad Sci U S A. 2004]Infect Immun. 2002 Mar; 70(3):1657-63.
[Infect Immun. 2002]Mol Microbiol. 1998 Jan; 27(2):323-36.
[Mol Microbiol. 1998]Mol Microbiol. 1998 Jan; 27(2):323-36.
[Mol Microbiol. 1998]Mol Microbiol. 2004 Jul; 53(1):29-40.
[Mol Microbiol. 2004]Infect Immun. 2006 Jun; 74(6):3597-606.
[Infect Immun. 2006]Proc Natl Acad Sci U S A. 2005 Mar 29; 102(13):4866-71.
[Proc Natl Acad Sci U S A. 2005]Infect Immun. 2005 Sep; 73(9):5720-34.
[Infect Immun. 2005]Science. 1966 Mar 25; 151(717):1543-4.
[Science. 1966]J Biotechnol. 2001 Oct 4; 91(2-3):211-21.
[J Biotechnol. 2001]J Lipid Res. 1984 Dec 15; 25(13):1501-7.
[J Lipid Res. 1984]Mol Microbiol. 2001 Mar; 39(5):1186-98.
[Mol Microbiol. 2001]J Bacteriol. 2006 Mar; 188(5):1929-34.
[J Bacteriol. 2006]Infect Immun. 1998 Jul; 66(7):3029-34.
[Infect Immun. 1998]Mol Microbiol. 2004 Jul; 53(1):29-40.
[Mol Microbiol. 2004]Infect Immun. 2005 Sep; 73(9):5720-34.
[Infect Immun. 2005]J Biol Chem. 1999 Apr 30; 274(18):12339-45.
[J Biol Chem. 1999]J Lipid Res. 1984 Dec 15; 25(13):1501-7.
[J Lipid Res. 1984]Mol Microbiol. 2000 Jul; 37(1):13-27.
[Mol Microbiol. 2000]Nature. 1995 Oct 5; 377(6548):435-8.
[Nature. 1995]Mol Microbiol. 1993 Jan; 7(1):7-19.
[Mol Microbiol. 1993]Mol Microbiol. 2003 Apr; 48(2):305-21.
[Mol Microbiol. 2003]Infect Immun. 1995 Sep; 63(9):3609-20.
[Infect Immun. 1995]Mol Microbiol. 2003 Apr; 48(2):305-21.
[Mol Microbiol. 2003]Mol Microbiol. 1993 Jan; 7(1):7-19.
[Mol Microbiol. 1993]Mol Microbiol. 2003 Apr; 48(2):305-21.
[Mol Microbiol. 2003]Can J Biochem Physiol. 1959 Aug; 37(8):911-7.
[Can J Biochem Physiol. 1959]J Bacteriol. 1997 Nov; 179(22):6921-8.
[J Bacteriol. 1997]Mol Microbiol. 2003 Apr; 48(2):305-21.
[Mol Microbiol. 2003]Mol Microbiol. 2003 Apr; 48(2):305-21.
[Mol Microbiol. 2003]J Histochem Cytochem. 1974 Dec; 22(12):1077-83.
[J Histochem Cytochem. 1974]Mol Microbiol. 2003 Apr; 48(2):305-21.
[Mol Microbiol. 2003]Mol Microbiol. 1998 Jan; 27(2):323-36.
[Mol Microbiol. 1998]Mol Microbiol. 2003 Apr; 48(2):305-21.
[Mol Microbiol. 2003]Proc Natl Acad Sci U S A. 2004 Jan 20; 101(3):841-6.
[Proc Natl Acad Sci U S A. 2004]Mol Microbiol. 2003 Apr; 48(2):305-21.
[Mol Microbiol. 2003]Mol Microbiol. 2000 Jul; 37(1):13-27.
[Mol Microbiol. 2000]Infect Immun. 2006 Jun; 74(6):3597-606.
[Infect Immun. 2006]Microbiology. 2003 Dec; 149(Pt 12):3461-71.
[Microbiology. 2003]J Biotechnol. 2001 Oct 4; 91(2-3):211-21.
[J Biotechnol. 2001]Mol Microbiol. 2003 Apr; 48(2):305-21.
[Mol Microbiol. 2003]Mol Microbiol. 2003 Apr; 48(2):305-21.
[Mol Microbiol. 2003]